Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: A complex interplay between estrogen receptors α and β

Cancer Research

Volumn 62, Issue 17, 2002, Pages 4977-4984

  Buteau Lozano, Hélène ^a   Ancelin, Magali ^a   Lardeux, Bernard ^b   Milanini, Julie ^c   Perrot Applanat, Martine ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; TAMOXIFEN; VASCULOTROPIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTROGEN RESPONSIVE ELEMENT; GENE ACTIVITY; GENE CONSTRUCT; GENE DELETION; GENE INDUCTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOKINES; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; RNA, MESSENGER; TAMOXIFEN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036731988     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
2. Angioganesis in cancer, vascular, rheumatoid, and other disease
3. Mechanisms of angioganesis and arterioganesis
4. The biology of vascular endothelial growth factor
5. Clinical applications of angiogenic growth factors and their inhibitors
6. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
7. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma
8. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
9. Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival
10. Vascular endothelial growth factor (VEGF) in breast cancer: Comparison of plasma, serum, and tissues VEGF and microvessel density and effects of tamoxifen
11. Vascular endothelial growth factor/vascular permeability factor expression on the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth
12. Ovarian steroid regulation of vascular endothelial growth factor in human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
13. Paracrine action of vascular endothelial growth factor in the human endometrium: Production and target sites, and hormonal regulation
14. Vascular endothelial growth factor is essential for corpus luteam angioganesis
15. The effect of estrogen on aromatase and vascular endothelial growth factor messenger ribonucleic acid in the normal non-human primate mammary gland
16. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
17. Progestin regulation of vascular endothelial growth factor in human breast cancer cells
18. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells
19. Estradiol, tamoxifen and hypoxia modulate vascular endothelial growth factor in human vascular smooth muscle cells
20. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β
21. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
22. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
23. Immunolocalisation of estrogen receptor β in human tissues
24. Insights from the study of animals lacking functional estrogen receptor
25. Generation and reproductive phenotypes of mice lacking estrogen receptor β
26. Altered estrogen receptor α and β messenger RNA expression during human breast tumorigenesis
27. Estrogen receptor β is coexpressed with ERα and PR and associated with nodal status, grade, and proliferation rate in breast cancer
28. Estrogen receptor-β messenger RNA expression in human breast tumor biopsies: Relationship to steroid receptor status and regulation by progestins
29. Coexpression of estrogen receptor α and β: Poor prognostic factors in human breast cancer?
30. Decreased expression of estrogen receptor β protein in proliferative preinvasive mammary tumor
31. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
32. Transforming growth factor-α-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2 dependent DNA binding and transactivation
33. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
34. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids
35. The human gene for vascular endothelial growth factor
36. Human estrogen receptor cDNA: Sequence, expression and homology to v-erb-A
37. Dominant negative and cooperative effects of mutant forms of prolactin receptor
38. Presence of estrogen receptor β in the human endometrium through the cycle: Expression in glandular, stromal, and vascular cells
39. Cell-free activation of a DNA-binding protein by epidermal growth factor
40. Presence of AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation
41. Immunolocalization of steroid hormone receptors in normal and turnout cells. Mechanisms of their cellular traffic
42. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: Functional difference between receptors a and β
43. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
44. Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites
45. Estrogen regulated vascular endothelial growth/permeability factor expression in 7.12-dimethylbenz(a)anthracene-induced rat mammary tumors
46. A comparison of transcriptional activation by ER a and ER β
47. ERβ inhibits proliferation and invasion of breast cancer cells
48. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor
49. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen
50. Estrogen receptor pathways to AP-1
51. Estrogen receptors α and β form heterodimers on DNA
52. Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α
53. Estrogen receptor α acts as a dominant regulator of estrogen signaling
54. Differential expression of estrogen receptor α and β messenger RNAs as a potential marker of ovarian carcinogenesis
55. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice
56. Antiestrogens inhibit endothelial cell growth stimulated by angiogenic-growth factors
57. Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients
58. The effect of tamoxifen on breast tumor vascularity
59. Increased expression of estrogen receptor β mRNA in tamoxifen-resistant breast cancer patients